Glioblastoma_A malignant Brain Tumor
ITM, Helmholtz Munich and University Hospital Münster Announce Start of Phase I Clinical Trial with Radiotherapeutic ITM-31 for Glioblastoma
March 13, 2023 06:13 ET | ITM Isotope Technologies Munich SE
Garching/Munich, Munich and Münster, Germany, March 13, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, Helmholtz Munich and the Departments of...
ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177
July 21, 2022 05:21 ET | ITM Isotope Technologies Munich SE
ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs’ Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA Complex for GD2-positive...
ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
June 21, 2022 11:45 ET | ITM Isotope Technologies Munich SE
First-of-a-kind Isotope Production System continues to progress towards commercial, industrial-scale production of medical isotopes for cancer therapeutics ONTARIO, CANADA, and MUNICH, GERMANY – June...
Making Our COVID Survivors Whole Again By Solving Yet Another Desperate Shortage
August 03, 2020 08:30 ET | US Nuclear Corp.
LOS ANGELES, CA, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – US Nuclear Corp. (OTC: UCLE) aims to combat COVID-19 and help patients and survivors of the virus by working together with...
The Desperate Need for Medical Isotopes
March 18, 2019 08:30 ET | US Nuclear Corp.
LOS ANGELES, CA, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – With preparations underway for manufacturing the MIFTEC Z-pinch (ZEBRA) Fusion Medical Isotope Generators, US Nuclear Corp....
UPPI logo bug color2016c (002).jpg
UPPI LLC Presents at the Nuclear Energy Agency's 4th Meeting of the 4th Mandate of the High-level Group on the Security of the Medical Radioisotope Supply
August 28, 2017 07:00 ET | UPPI, LLC
SUWANEE, GA--(Marketwired - August 28, 2017) - UPPI LLC announced today it presented an update on the UPPI LEU Walk and initiatives to transition to non-HEU (non-Highly Enriched Uranium) medical...